Elevance Health, Inc (ELV)

$502.42

-1.47

(-0.29%)

Market is closed - opens 7 PM, 24 Jul 2024
star icon

Elevance Health Inc is a healthcare company that leverages data analytics and artificial intelligence to improve patient outcomes and reduce healthcare costs.

Performance

  • $501.35
    $507.16
    $502.42
    downward going graph

    0.21%

    Downside

    Day's Volatility :1.15%

    Upside

    0.93%

    downward going graph
  • $427.37
    $555.36
    $502.42
    downward going graph

    14.94%

    Downside

    52 Weeks Volatility :23.05%

    Upside

    9.53%

    downward going graph

Returns

PeriodElevance Health, IncSector (Health Care)S&P500
3 Months
-5.87%
5.5%
9.5%
6 Months
6.07%
7.2%
14.1%
1 Year
6.63%
9.3%
22.0%
3 Years
32.74%
13.0%
25.9%

Highlights

Market Capitalization
116.8B
Book Value
$181.94
Dividend Share
6.22
Dividend Yield
1.29%
Earnings Per Share (EPS)
28.57
PE Ratio
17.63
PEG Ratio
1.14
Wall Street Target Price
599.13
Profit Margin
3.9%
Operating Margin TTM
6.93%
Return On Assets TTM
5.93%
Return On Equity TTM
16.58%
Revenue TTM
171.7B
Revenue Per Share TTM
735.1
Quarterly Revenue Growth YOY
-0.1%
Gross Profit TTM
40.1B
EBITDA
11.4B
Diluted Eps TTM
28.57
Quarterly Earnings Growth YOY
0.26
EPS Estimate Current Year
37.26
EPS Estimate Next Year
41.67
EPS Estimate Current Quarter
10.01
EPS Estimate Next Quarter
9.82

Analyst Recommendation

Buy
    84%Buy
    15%Hold
    0
    0%Sell
Based on 26 Wall street analysts offering stock ratings for Elevance Health, Inc(by analysts ranked 0 to 5 stars)
Based on 26 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
22
22
19
Hold
4
4
4
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 19.25%

Current $502.42
Target $599.13

Company Financials

FY18Y/Y Change
Revenue
92.1B
↑ 2.29%
Net Income
3.8B
↓ 2.41%
Net Profit Margin
4.07%
↓ 0.2%
FY19Y/Y Change
Revenue
104.2B
↑ 13.15%
Net Income
4.8B
↑ 28.19%
Net Profit Margin
4.61%
↑ 0.54%
FY20Y/Y Change
Revenue
121.9B
↑ 16.94%
Net Income
4.6B
↓ 4.89%
Net Profit Margin
3.75%
↓ 0.86%
FY21Y/Y Change
Revenue
138.6B
↑ 13.76%
Net Income
6.2B
↑ 34.69%
Net Profit Margin
4.44%
↑ 0.69%
FY22Y/Y Change
Revenue
156.6B
↑ 12.95%
Net Income
5.9B
↓ 4.29%
Net Profit Margin
3.76%
↓ 0.68%
FY23Y/Y Change
Revenue
171.3B
↑ 9.42%
Net Income
6.0B
↑ 1.58%
Net Profit Margin
3.49%
↓ 0.27%
Q1 FY23Q/Q Change
Revenue
42.2B
↑ 8.15%
Net Income
2.0B
↑ 105.12%
Net Profit Margin
4.75%
↑ 2.24%
Q2 FY23Q/Q Change
Revenue
43.7B
↑ 3.56%
Net Income
1.9B
↓ 7.53%
Net Profit Margin
4.24%
↓ 0.51%
Q3 FY23Q/Q Change
Revenue
42.8B
↓ 1.88%
Net Income
1.3B
↓ 30.44%
Net Profit Margin
3.01%
↓ 1.23%
Q4 FY23Q/Q Change
Revenue
42.6B
↓ 0.47%
Net Income
856.0M
↓ 33.59%
Net Profit Margin
2.01%
↓ 1.0%
Q1 FY24Q/Q Change
Revenue
42.6B
↓ 0.16%
Net Income
2.2B
↑ 162.38%
Net Profit Margin
5.28%
↑ 3.27%
Q2 FY24Q/Q Change
Revenue
43.6B
↑ 2.51%
Net Income
2.3B
↑ 2.4%
Net Profit Margin
5.27%
↓ 0.01%
FY18Y/Y Change
Total Assets
71.6B
↑ 1.46%
Total Liabilities
43.0B
↓ 2.29%
FY19Y/Y Change
Total Assets
77.5B
↑ 8.22%
Total Liabilities
45.7B
↑ 6.26%
FY20Y/Y Change
Total Assets
86.6B
↑ 11.83%
Total Liabilities
53.4B
↑ 16.82%
FY21Y/Y Change
Total Assets
97.3B
↑ 12.34%
Total Liabilities
61.2B
↑ 14.53%
FY22Y/Y Change
Total Assets
102.8B
↑ 5.62%
Total Liabilities
66.4B
↑ 8.5%
FY23Y/Y Change
Total Assets
108.9B
↑ 5.99%
Total Liabilities
69.5B
↑ 4.74%
Q1 FY23Q/Q Change
Total Assets
109.0B
↑ 6.1%
Total Liabilities
71.6B
↑ 7.84%
Q2 FY23Q/Q Change
Total Assets
109.2B
↑ 0.12%
Total Liabilities
70.9B
↓ 1.01%
Q3 FY23Q/Q Change
Total Assets
110.5B
↑ 1.2%
Total Liabilities
71.9B
↑ 1.53%
Q4 FY23Q/Q Change
Total Assets
108.9B
↓ 1.4%
Total Liabilities
69.5B
↓ 3.36%
Q1 FY24Q/Q Change
Total Assets
111.9B
↑ 2.72%
Total Liabilities
71.2B
↑ 2.39%
Q2 FY24Q/Q Change
Total Assets
113.0B
↑ 0.98%
Total Liabilities
70.7B
↓ 0.69%
FY18Y/Y Change
Operating Cash Flow
3.8B
↓ 8.55%
Investing Cash Flow
-1.3B
↓ 75.23%
Financing Cash Flow
-2.2B
↓ 624.95%
FY19Y/Y Change
Operating Cash Flow
6.1B
↑ 58.37%
Investing Cash Flow
-2.8B
↑ 121.76%
Financing Cash Flow
-2.3B
↑ 1.12%
FY20Y/Y Change
Operating Cash Flow
10.7B
↑ 76.34%
Investing Cash Flow
-7.3B
↑ 162.32%
Financing Cash Flow
-2.6B
↑ 13.28%
FY21Y/Y Change
Operating Cash Flow
8.4B
↓ 21.74%
Investing Cash Flow
-9.6B
↑ 31.59%
Financing Cash Flow
423.0M
↓ 116.48%
FY22Y/Y Change
Operating Cash Flow
8.4B
↑ 0.42%
Investing Cash Flow
-4.6B
↓ 52.69%
Financing Cash Flow
-1.3B
↓ 411.58%
Q1 FY23Q/Q Change
Operating Cash Flow
6.5B
↓ 526.15%
Investing Cash Flow
-3.2B
↓ 30.18%
Financing Cash Flow
-531.0M
↑ 105.81%
Q2 FY23Q/Q Change
Operating Cash Flow
2.0B
↓ 69.86%
Investing Cash Flow
-672.0M
↓ 78.89%
Financing Cash Flow
-1.4B
↑ 169.3%
Q3 FY23Q/Q Change
Operating Cash Flow
2.6B
↑ 34.0%
Investing Cash Flow
-4.5B
↑ 576.04%
Financing Cash Flow
-994.0M
↓ 30.49%

Technicals Summary

Sell

Neutral

Buy

Elevance Health, Inc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Elevance Health, Inc
Elevance Health, Inc
-7.25%
6.07%
6.63%
32.74%
73.9%
The Cigna Corp
The Cigna Corp
-2.03%
10.4%
15.1%
47.16%
96.27%
Unitedhealth Group Incorporated
Unitedhealth Group Incorporated
13.21%
8.08%
9.05%
34.13%
120.88%
Cvs Health Corporation
Cvs Health Corporation
-6.09%
-21.86%
-23.67%
-30.05%
3.54%
Humana Inc.
Humana Inc.
7.77%
-4.11%
-14.9%
-17.43%
39.76%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Elevance Health, Inc
Elevance Health, Inc
17.63
17.63
1.14
37.26
0.17
0.06
0.01
181.94
The Cigna Corp
The Cigna Corp
27.55
27.55
0.89
28.5
0.09
0.03
0.02
144.9
Unitedhealth Group Incorporated
Unitedhealth Group Incorporated
37.46
37.46
1.24
27.71
0.16
0.07
0.01
102.02
Cvs Health Corporation
Cvs Health Corporation
10.45
10.45
1.0
6.98
0.1
0.03
0.04
59.08
Humana Inc.
Humana Inc.
23.87
23.87
1.64
16.34
0.12
0.05
0.01
133.86
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Elevance Health, Inc
Elevance Health, Inc
Buy
$116.8B
73.9%
17.63
3.9%
The Cigna Corp
The Cigna Corp
Buy
$95.4B
96.27%
27.55
1.77%
Unitedhealth Group Incorporated
Unitedhealth Group Incorporated
Buy
$520.3B
120.88%
37.46
3.66%
Cvs Health Corporation
Cvs Health Corporation
Buy
$74.8B
3.54%
10.45
2.04%
Humana Inc.
Humana Inc.
Buy
$46.7B
39.76%
23.87
1.82%

Insights on Elevance Health, Inc

  • Increasing Revenue

    Revenue is up for the last 2 quarters, 42.57B → 43.64B (in $), with an average increase of 2.5% per quarter

  • Increasing Net Profit

    Netprofit is up for the last 3 quarters, 856.0M → 2.3B (in $), with an average increase of 32.1% per quarter

  • Vs CI

    In the last 1 year, The Cigna Corp has given 15.1% return, outperforming this stock by 8.5%

  • Vs CI

    In the last 3 years, The Cigna Corp has given 44.4% return, outperforming this stock by 13.0%

Institutional Holdings

  • Vanguard Group Inc

    9.14%
  • BlackRock Inc

    9.00%
  • T. Rowe Price Associates, Inc.

    5.04%
  • State Street Corporation

    4.51%
  • Geode Capital Management, LLC

    2.02%
  • Sanders Capital, LLC

    1.94%

Corporate Announcements

  • Elevance Health, Inc Dividends March,2024

    In the quarter ending March,2024. Elevance Health, Inc has declared dividend of $1.63

    Read More

Company Information

Elevance Health, Inc. is an American health insurance provider. Prior to June 2022, Elevance Health was named Anthem, Inc.

Organization
Elevance Health, Inc
Employees
104900
CEO
Ms. Gail Koziara Boudreaux
Industry
Healthcare

FAQs